Systole Remedies Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 2005.
2005 Delhi, Delhi, India Active
Last Updated:
Access Report
About Systole Remedies Private Limited

Systole Remedies Private Limited, a active private limited company, was established on 24 January 2005 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230DL2005PTC191854. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.50 Cr.

It upholds a compliant status. Employing 9 professional, Its leadership includes Harsimran Singh Kalra (Additional Director), Ravneet Singh (Additional Director), Pawan Kumar (Person Incharge). Past directors included Tarsem Chand Kansal, Pawan Kumar, Sakshi Kansal. It holds ₹13.85 Cr open charges and ₹8.28 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at E-100 Kh-24/19, 20 Ft. Road West Karawal Nagar, Delhi, Delhi, 110094.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230DL2005PTC191854

  • Registration Number

    191854

  • Incorporation Date

    24 January 2005

  • Authorized Capital

    ₹1.50 Cr

  • Paid-Up Capital

    ₹1.50 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 Cr
  • Paid Up Capital ₹ 1.50 Cr
  • Company Age 21 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 13.85 Cr
  • Satisfied Charges ₹ 8.28 Cr
  • Revenue Growth **** 20.81%
  • Profit Growth **** 25.25%
  • Ebitda **** 561.21%
  • Net Worth 9.47%
  • Total Assets **** 11.99%
Company report

Systole Remedies Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Systole Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Systole Remedies Private Limited?
Current Directors
Name Designation Appointment Date Status
Harsimran Singh Kalra Additional Director 17 Jul 2021 Current
Ravneet Singh Additional Director 29 Jun 2021 Current
Pawan Kumar Person Incharge 01 Apr 2009 Current
Mandeep Singh Kalra Additional Director 13 Jul 2021 Current
Pavneet Singh Kalra Additional Director 13 Jul 2021 Current
Jitender Mohan Kalra Additional Director 29 Jun 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 22 Nov 2017 Past
Pramod Abcsdd Director 31 May 2020 Past
Pramod Abcsdd Director 01 Apr 2009 Past
Pramod Abcsdd Managing Director 13 Jul 2021 Past
Pramod Abcsdd Additional Director 02 May 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Systole Remedies.

Systole Remedies Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 20.81% increase. The company also saw a substantial improvement in profitability, with a 25.25% increase in profit. The company's net worth moved up by a moderate rise of 9.47%.

Systole Remedies revenue growth over time
Systole Remedies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 20.81%
*******
*******
*******
*******
Revenue from Operations
*******
 21.04%
*******
*******
*******
*******
Total Assets
*******
 11.99%
*******
*******
*******
*******
Profit or Loss
*******
 25.25%
*******
*******
*******
*******
Net Worth
*******
 9.47%
*******
*******
*******
*******
EBITDA
*******
 561.21%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Systole Remedies?

In 2024, Systole Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹138,500,000.00

Satisfied Charges

₹82,750,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 11.35 Cr
  • Hdfc Bank Limited : 2.50 Cr
Latest Charge Details
Date Lender Amount Status
21 Apr 2025 Axis Bank Limited ₹4.35 Cr Open
30 Mar 2023 Axis Bank Limited ₹7.00 Cr Open
03 Feb 2022 Hdfc Bank Limited ₹2.50 Cr Open
29 Sep 2020 Others ₹2.75 M Satisfied
30 Dec 2015 Others ₹2.75 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Systole Remedies?

Systole Remedies has a workforce of 9 employees as of Mar 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Systole Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Systole Remedies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Systole Remedies
Recent Activity within the Organization
  • Director Appointment

    The activity Ashok Thakur was appointed as a Director was appointed as a Director on 01 Oct 2025 & has been associated with this company since 4 months 30 days . was completed.

  • Charges

    A charge with Axis Bank Limited of Rs. 7.00 Cr registered on 30 Mar 2023 with Charge ID 100706173 was modified on 29 Apr 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Axis Bank Limited amounted to Rs. 4.35 Cr with Charge ID 101085773 was registered on 21 Apr 2025. was completed.

  • Annual General Meeting

    Progress on Systole Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Systole Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.

  • Charges

    The activity A charge with Axis Bank Limited amounted to Rs. 7.00 Cr with Charge ID 100706173 was registered on 30 Mar 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Systole Remedies Private Limited?

The CIN of Systole Remedies Private Limited is U24230DL2005PTC191854.

Where is Systole Remedies Private Limited headquartered?

Systole Remedies Private Limited is headquartered at E-100 Kh-24/19, 20 Ft. Road West Karawal Nagar, Delhi, Delhi, 110094.

When was Systole Remedies Private Limited incorporated?

Systole Remedies Private Limited was incorporated on 24 January 2005.

Who are the current directors of Systole Remedies Private Limited?

The current directors of Systole Remedies Private Limited are

What is the primary industry of Systole Remedies Private Limited?

The primary industry of Systole Remedies Private Limited is Manufacturing.

Is Systole Remedies Private Limited a listed company?

Systole Remedies Private Limited is unlisted.

What is the capital structure of Systole Remedies Private Limited?

The authorized capital of Systole Remedies Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.50 Cr.

What is the compliance status of Systole Remedies Private Limited?

The compliance status of Systole Remedies Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available